Then, a possible role for C4ORF19 in ICB treatment of ccRCC was explored by analyzing the association between C4ORF19 and ICB key targets adjusted for tumor purity using TIMER. The gene discussed is PGCKA1; the disease is nonpapillary renal cell carcinoma.